Pharmacological Properties of Faster-Acting Insulin Aspart.

about

Pharmacological Properties of Faster-Acting Insulin Aspart.

Item

http://www.wikidata.org/entity/Q47937602

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacological Properties of Faster-Acting Insulin Aspart.

@en

Pharmacological Properties of Faster-Acting Insulin Aspart.

@nl

type

Item

label

Pharmacological Properties of Faster-Acting Insulin Aspart.

@en

Pharmacological Properties of Faster-Acting Insulin Aspart.

@nl

prefLabel

Pharmacological Properties of Faster-Acting Insulin Aspart.

@en

Pharmacological Properties of Faster-Acting Insulin Aspart.

@nl

P1476

Pharmacological Properties of Faster-Acting Insulin Aspart.

@en

P2093

Olga Kordonouri

http://www.w3.org/2001/XMLSchema#string

Thomas Danne

http://www.w3.org/2001/XMLSchema#string

P2860

A review of a family of ultra-rapid-acting insulins: formulation development

[Significance of insulin analogues in the treatment of people with type 2 diabetes].

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.

Design of non-standard insulin analogs for the treatment of diabetes mellitus

The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries.

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration.

Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA.

Getting closer to physiologic insulin secretion.

P2888

s11892-017-0931-y

P304

101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-017-0931-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Torben Biester

P577

2017-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28940145

http://www.w3.org/2001/XMLSchema#string